Govt approves Bharat Biotech's Covid-19 nasal vaccine: All you need to know

Government Nod To
Nasal Vaccine

Bharat Biotech’s Covid-19 nasal vaccine Incovacc has received the government’s approval for use as a booster dose on Dec 23 

Incovacc Availability 

Bharat Biotech's intranasal Covid vaccine will be available in private centres and will be introduced on CoWIN on Dec 23, as per an India Today report

Incovacc’s Approvals 

Incovacc received a go ahead from the Central Drugs Standard Control Organisation for restricted use in emergency situations for people aged 18 and above few weeks ago 

All About Incovacc

The government in its press release called Incovacc the ‘World’s first intra-nasal vaccine for Covid’. Here’s everything to know about the nasal vaccine

How To Administer

The nasal vaccine is administered through the nose, as a 2-dose series, four weeks apart. A total of 8 drops (0.5 ml per dose), 4 drops are administered into each nostril

Pros Of Incovacc

The delivery process is non-invasive and needle-free. Thus, avoiding needle-associated risks like injuries and infections 

Simple-Delivery Process 

Due to the simple-delivery process, Bharat Biotech’s new nasal vaccine does not require trained health-care workers to administer the booster dose 

Possible Side-Effects 

As per Bharat Biotech, reported side-effects observed during clinical trials include headache, fever, running nose and sneezing. However, severe side effects are rare

Candidates Not Fit
For Incovacc

Bharat Biotech advises against receiving a dose for individuals who:
-Have a severe allergic reaction to any ingredients of the vaccine 
-Had a severe allergic reaction after a previous dose of this vaccine 
-Currently have an acute infection or fever

Best of JioSaavn 2022: Sidhu Moose Wala’s The Last Ride, Beast’s Arabic Kuthu

Next Visual Story 

Produced By: Anshula Raj 
Designed By: Mohsin

Click Here

Next: What Is BF.7 Covid Variant? China's New Covid Variant Reaches India